Search Results 581-590 of 16165 for monoclonal antibody

  1. Contact - Antibody Hybridoma Core - Mayo Clinic Research

    Contact the Antibody Hybridoma Core at Mayo Clinic's campus in Rochester, Minnesota, to request services or schedule a consultation.

  2. DeeDee Stiepan | Mayo Clinic News Network - Page 17 of 25

    Monoclonal antibody treatment can help high-risk patients with COVID-19. By DeeDee Stiepan • December 4, 2020. Mayo Clinic leader discusses post-Thanksgiving ...

  3. Antibody Barriers Project - Transplant Immunology Program - Mayo Clinic Research

    ... antibody barriers to immediate and long-term transplant success. One example of these barriers is the action of antibodies against human leukocyte antigens ...

  4. Publications - Jack C. O'Horo, M.D., M.P.H. - Mayo Clinic

    Neutralizing Monoclonal Antibody Use and COVID-19 Infection Outcomes. JAMA Netw Open. 2023 Apr 3; 6 (4):e239694 Epub 2023 Apr 03. View PubMed; Matson RP ...

  5. Surgery - Clinical trials

    Monoclonal antibodies, such as nivolumab and ipilimumab, may interfere with the ability of tumor cells to grow and spread. Stereotactic radiosurgery is a ...

  6. Cancer Treatment Clinical Trials - Mayo Clinic Research

    Monoclonal antibodies, such as ... Part 1 is a dose escalation study ... Phase 1/2 Dose Escalation and Efficacy Study of Anti-CD38 Monoclonal Antibody ...

  7. Rho(d) immune globulin (injection route, intramuscular route, intravenous route) - Mayo Clinic

    ... antibodies. When the same woman has a second baby with Rh-positive blood, the antibodies will destroy the red blood cells in the baby. Rho(D) immune ...

  8. Cancer Clinical Trials - Mayo Clinic Research

    Monoclonal antibodies, such as rituximab may block tumor growth in different ways by targeting certain cells. LMP-specific T-cells are special immune system ...

  9. Migraine is a genetic neurologic disease that often goes undiagnosed and undertreated. Sometimes migraine headaches come with pa

    CGRP, monoclonal antibodies. Amaal Starling, M.D.. Neurology. Mayo Clinic. "We're using that technology to create antibodies designed to target one specific ...

  10. Assessing Pre-existing Antibodies to AAV in a Population of Patients With PKP2-Associated ARVC - Mayo Clinic

    Currently receiving systemic immunosuppressive therapy, cytotoxic chemotherapy, immunoglobulin therapy, or monoclonal antibody therapy. History of ...